India may get COVID-19 antibody by mid 2021: Bernstein Kumar Jeetendra | August 28, 2020 India is likely to acquire an approved COVID-19 vaccine by the first quarter of 2021, global brokerage firm Bernstein said in a report. “We’re optimistic that there will be an approved vaccine in the marketplace by 1Q calendar year 2021 in India,” the report stated. While the vaccine may be available at USD 3-6 (Rs …
90 Percent of China’s Sinovac Workers, Households took coronavirus vaccine, says CEO Kumar Jeetendra | September 7, 2020 Approximately 90 percent of Sinovac Biotech Ltd employees and their families have obtained an experimental coronavirus vaccine developed by the Chinese company under the nation’s emergency usage programme, its chief executive said on Sunday. The extent of inoculations under the emergency programme, which China launched in July but has released few details about, points to …
India preliminaries for Russia’s ‘Sputnik-V’ antibody may start in next barely any weeks: Dr Reddy’s Kumar Jeetendra | September 22, 2020 Reddy’s Laboratories Ltd could start late-stage Indian clinical trials of Russia’s potential coronavirus vaccine within the next few months, an executive in the Indian drugmaker said on Tuesday. Indian trials of this Sputnik-V vaccine candidate, being developed by Russia’s sovereign wealth fund, will enroll 1,000-2,000 participants and also be conducted at multiple private and government …
